Novartis, Myriad Get Boost After Court Patent Ruling
Novartis, Myriad Get Boost After Court Patent Ruling
Myriad Genetics Inc., Genomic Health Inc. and the rest of the burgeoning industry for personalized medicine stand to gain from yesterday’s landmark U.S. Supreme Court decision on patenting business methods.
Read more on BusinessWeek